Literature DB >> 12496906

Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer.

D F Penson1, M S Litwin, D P Lubeck, S Flanders, D J Pasta, P R Carroll.   

Abstract

Health-Related Quality of Life (HRQOL) is an important outcome measure in the study of prostate cancer. There are few data regarding the effect of sociodemographic variables, such as insurance status, educational level, marital status or income, on HRQOL. We examined whether these or other sociodemographic and clinical variables are predictive of HRQOL outcomes using an observational database of prostate cancer patients accrued from a wide array of clinical practice settings. We studied 131 patients with newly-diagnosed prostate cancer who had been followed for at least nine months. Patients were enrolled in CaPSURE(TM), a large, observational database of patients with prostate cancer. General and disease-specific HRQOL were measured with established, validated instruments at diagnosis and nine months later. Sociodemographic data and co-morbidity counts were recorded at baseline. Multivariate regression analysis was used to determine whether sociodemographic or clinical variables were predictive of baseline HRQOL or HRQOL changes during the study period. Several sociodemographic and clinical variables demonstrated significant associations with HRQOL. We found improvements in general and disease-specific domains of HRQOL during the nine months after diagnosis. For married patients, Emotional Well-Being and Family Functioning scores were better at baseline (+11.8, P<0.02), but Family Functioning declined over the nine month study period (-18.5, P=0.0006). Older patients had slightly better baseline performance in several domains of HRQOL, but experienced greater HRQOL decrements over time than did younger patients. Increasing comorbidity was associated with worse baseline general HRQOL. Early tumor stage was predictive of better scores in general HRQOL domains at baseline. Limited palpable disease stage (T2A/T2B) was predictive of worse Sexual Function and Sexual Bother at nine months (-8.6, P=0.04; -24, P=0.008). After initial decreases, patients appear to experience an improvement in general and disease-specific HRQOL within nine months of initial diagnosis with prostate cancer. Marital status is associated with better HRQOL, while advancing age is associated with more significant HRQOL declines over time. Patients with lower stage disease were noted to have better general HRQOL at baseline, although decreases in the physical domains were noted at nine months. These data shed new light on patients' experience with prostate cancer and suggest that HRQOL outcomes over time may occur in a predictable manner.

Entities:  

Year:  1998        PMID: 12496906     DOI: 10.1038/sj.pcan.4500228

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  4 in total

Review 1.  Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation.

Authors:  Lisa Kennedy; Ann-Marie Craig
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer.

Authors:  Kirsi Talala; Sirpa Heinävaara; Kimmo Taari; Teuvo L J Tammela; Paula Kujala; Ulf-Håkan Stenman; Nea Malila; Anssi Auvinen
Journal:  Cancer Med       Date:  2020-06-04       Impact factor: 4.452

Review 3.  Quality of life following prostate cancer treatments.

Authors:  D F Penson
Journal:  Curr Urol Rep       Date:  2000-05       Impact factor: 2.862

4.  Quality of life in lung cancer patients: does socioeconomic status matter?

Authors:  Ali Montazeri; David J Hole; Robert Milroy; James McEwen; Charles R Gillis
Journal:  Health Qual Life Outcomes       Date:  2003-06-09       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.